Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05927233

Effect of Methylprednisolone on Systemic Inflammatory Response During Pediatric Congenital Open-Heart Surgery

Effect of Methylprednisolone on Systemic Inflammatory Response and Clinical Parameters During Pediatric Congenital Open-Heart Surgery: A Randomized Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Aga Khan University · Academic / Other
Sex
All
Age
1 Month – 18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate the effects of steroids on the early postoperative inflammatory response in patients undergoing elective pediatric congenital cardiac surgery, requiring cardiopulmonary bypass (CPB).

Conditions

Interventions

TypeNameDescription
DRUGMethylprednisolone30 ml Methylprednisolone (30mg/kg) with a maximum dose of 500 mg
DRUGSaline30 ml Normal saline

Timeline

Start date
2023-04-01
Primary completion
2025-04-30
Completion
2025-06-30
First posted
2023-07-03
Last updated
2024-07-31

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05927233. Inclusion in this directory is not an endorsement.

Effect of Methylprednisolone on Systemic Inflammatory Response During Pediatric Congenital Open-Heart Surgery (NCT05927233) · Clinical Trials Directory